Literature DB >> 29102976

Giant phaeochromocytoma presenting with an acute stroke: reappraising phaeochromocytoma surveillance for the neurofibromatosis type 1 phakomatosis.

Yingshan Lee1, Leon Yuan Rui Tan2, Yong Howe Ho3, Melvin Khee Shing Leow1.   

Abstract

Neurofibromatosis type 1 (NF1) is a multisystem genetic disorder associated with reduced lifespan attributed largely to malignancy and vascular causes. One of the tumours associated with NF1 is phaeochromocytoma. The phaeochromocytoma has earned the moniker, a 'great mimicker', due to its varied means of presentation. We present a patient with NF1 who was diagnosed with a giant 20 cm phaeochromocytoma after suffering from an ischaemic stroke. Current guidelines do not advocate surveillance of phaeochromocytoma in asymptomatic patients with NF1, unlike other genetic syndromes associated with phaeochromocytoma. However, there is increasing evidence that this approach may not help in the early detection and treatment of this potentially life-threatening disease. Our patient remained hypertensive after surgery despite achieving biochemical cure. The suggested chronicity of the underlying tumour in our patient is a reminder to practising clinicians to rethink our strategy in identifying phaeochromocytoma in adults with NF1. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  adrenal disorders; endocrine cancer; genetic screening / counselling; hypertension; stroke

Mesh:

Year:  2017        PMID: 29102976      PMCID: PMC5747830          DOI: 10.1136/bcr-2017-222553

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  34 in total

1.  Evaluation and management of hypertension in childhood.

Authors:  J T. Flynn
Journal:  Prog Pediatr Cardiol       Date:  2001-01

Review 2.  Insights into the pathogenesis of neurofibromatosis 1 vasculopathy.

Authors:  S J Hamilton; J M Friedman
Journal:  Clin Genet       Date:  2000-11       Impact factor: 4.438

3.  Changes in clinical features and long-term prognosis in patients with pheochromocytoma.

Authors:  T Noshiro; K Shimizu; T Watanabe; H Akama; S Shibukawa; W Miura; S Ito; Y Miura
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

4.  High incidence of cardiovascular complications in pheochromocytoma.

Authors:  T Zelinka; O Petrák; H Turková; R Holaj; B Strauch; M Kršek; A B Vránková; Z Musil; J Dušková; J Kubinyi; D Michalský; K Novák; J Widimský
Journal:  Horm Metab Res       Date:  2012-04-19       Impact factor: 2.936

5.  Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.

Authors:  Lucinda M Gruber; Dana Erickson; Dusica Babovic-Vuksanovic; Geoffrey B Thompson; William F Young; Irina Bancos
Journal:  Clin Endocrinol (Oxf)       Date:  2016-08-26       Impact factor: 3.478

6.  Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1.

Authors:  Lori Képénékian; Thomas Mognetti; Jean-Christophe Lifante; Anne-Laure Giraudet; Claire Houzard; Stéphane Pinson; Françoise Borson-Chazot; Patrick Combemale
Journal:  Eur J Endocrinol       Date:  2016-07-22       Impact factor: 6.664

7.  Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.

Authors:  M Zöller; B Rembeck; H O Akesson; L Angervall
Journal:  Acta Derm Venereol       Date:  1995-03       Impact factor: 4.437

Review 8.  Health supervision for children with neurofibromatosis.

Authors:  Joseph H Hersh
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

9.  Hypertension in children with neurofibromatosis.

Authors:  R Virdis; P Balestrazzi; M Zampolli; A Donadio; M Street; E Lorenzetti
Journal:  J Hum Hypertens       Date:  1994-05       Impact factor: 3.012

10.  Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.

Authors:  Tu Anh Duong; Emilie Sbidian; Laurence Valeyrie-Allanore; Cédric Vialette; Salah Ferkal; Smaïl Hadj-Rabia; Christophe Glorion; Stanislas Lyonnet; Michel Zerah; Isabelle Kemlin; Diana Rodriguez; Sylvie Bastuji-Garin; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2011-05-04       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.